AstraZeneca supplies Kenya with non-mydriatic digital technologies to boost NCD screening
KENYA – AstraZeneca, a global pharmaceutical corporation, has supplied Kenya’s Ministry of Health with digital non-mydriatic research equipment that employs retinal cameras to assess a patient’s risk of already having or developing diabetes and hypertension through a single retinal screening.